Despite the slow trickle of updates on President Donald Trump’s proposed pharmaceutical import tariffs, drugmakers have ...

British drugmaker Hikma Pharmaceuticals reported a bigger-than-expected profit for 2023 on Thursday, helped by a strong performance of its generics businesses, but expects profit to be slightly ...